Regeneron Pharmaceuticals (REGN) Shareholder's Equity Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.18% |
| Dec 31, 2025 | 11.31% |
| Sep 30, 2025 | 13.03% |
| Jun 30, 2025 | 13.11% |
| Mar 31, 2025 | 13.85% |
| Dec 31, 2024 | 16.08% |
| Sep 30, 2024 | 19.33% |
| Jun 30, 2024 | 23.08% |
| Mar 31, 2024 | 31.11% |
| Dec 31, 2023 | 33.06% |
| Sep 30, 2023 | 34.99% |
| Jun 30, 2023 | 38.41% |
| Mar 31, 2023 | 24.64% |
| Dec 31, 2022 | 26.90% |
| Sep 30, 2022 | 26.85% |
| Jun 30, 2022 | 28.47% |
| Mar 31, 2022 | 28.23% |
| Dec 31, 2021 | 28.93% |
| Sep 30, 2021 | 29.93% |
| Jun 30, 2021 | 28.16% |
| Mar 31, 2021 | 22.18% |
| Dec 31, 2020 | 21.52% |
| Sep 30, 2020 | 18.72% |
| Jun 30, 2020 | 17.94% |
| Mar 31, 2020 | 35.60% |
| Dec 31, 2019 | 35.58% |
| Sep 30, 2019 | 32.74% |
| Jun 30, 2019 | 33.76% |
| Mar 31, 2019 | 35.87% |
| Dec 31, 2018 | 33.81% |
| Sep 30, 2018 | 33.64% |
| Jun 30, 2018 | 29.12% |
| Mar 31, 2018 | 30.26% |
| Dec 31, 2017 | 34.06% |
| Sep 30, 2017 | 33.35% |
| Jun 30, 2017 | 32.58% |
| Mar 31, 2017 | 30.07% |
| Dec 31, 2016 | 31.32% |
| Sep 30, 2016 | 38.51% |
| Jun 30, 2016 | 39.76% |
| Mar 31, 2016 | 38.85% |
| Dec 31, 2015 | 42.74% |
| Sep 30, 2015 | 59.93% |
| Jun 30, 2015 | 77.73% |
| Mar 31, 2015 | 361.86% |
| Dec 31, 2014 | 73.80% |
| Sep 30, 2014 | 81.29% |
| Jun 30, 2014 | 70.49% |
| Mar 31, 2014 | 62.21% |
| Dec 31, 2013 | 54.98% |
| Sep 30, 2013 | 69.34% |
| Jun 30, 2013 | 59.04% |
| Mar 31, 2013 | 53.84% |
| Dec 31, 2012 | 46.86% |
| Sep 30, 2012 | 24.03% |
| Jun 30, 2012 | 13.15% |